Additional information
| Active substance | Triptorelin |
|---|---|
| Storage conditions | Store in a refrigerator (2-8В°C) |
| Side effects | Hot flashes, mood alterations, decreased libido, pain at injection site, and long-term use can lead to bone density reduction |
| Effects | Reduces testosterone and estrogen production, leading to decreased tumor growth in hormone-sensitive cancers |
| Dosage (sports) | Not applicable as it is not used for performance enhancement in sports |
| Dosage (medical) | Typically 3.75 mg injected intramuscularly once every 4 weeks |
| Half-life | Approximately 3 hours |
| Main action | Reduces the release of gonadotropins and sex hormones by acting on pituitary GnRH receptors to induce a sustained desensitization effect |
| Substance class | Gonadotropin-releasing hormone (GnRH) agonist |
| Formula | C64H82N18O13 |
| Chemical name | Triptorelin acetate |
| Trade name | Decapeptyl, Trelstar, Gonapeptyl |
| Blood pressure | Can cause fluctuations, generally not significant |
| WAREHOUSE | International Warehouse 3 |
| Also known as | Diphereline, Gonapeptyl Depot |
| Lab Test | No specific lab tests but monitoring of hormone levels may be conducted |
| Aromatization | No |
| Hepatotoxicity | No |
| HBR | No |
| Water Retention | No |
| Acne | No |
| Use in sports | Not typically used in sports |
| Manufacturer | Beligas |
Reviews
There are no reviews yet.